Disulfiram has been used for several decades in the treatment of alcoholism. It now shows promise as an anti-cancer drug and radiosensitizer. Proposed mechanisms of action include the induction of oxidative stress and inhibition of proteasome activity. Our purpose was to determine the potential of disulfiram to enhance the anti-tumor efficacy of external beam γ-irradiation and 
used for the treatment of alcoholism for several decades. This drug also has a variety of other actions which suggest that it has potential as an anti-cancer agent. These include the induction of oxidative stress (2, 3) , the generation of copper-dependent toxicity (2, 4) , proteasome inhibition (4-6), and NF-κB inhibition (7, 8) . Despite its diverse range of pharmacological activities, prolonged treatment with disulfiram has negligible, reversible, adverse effects and is considered a safe drug (9) . Disulfiram is currently undergoing clinical trials for the treatment of various cancers including melanoma, liver, lung and prostate cancer. To determine the potential application of this agent in cancer therapy, it is important to understand its mechanisms of action as well as its effects in combination with other therapeutic modalities.
Disulfiram-induced cytotoxicity has previously been reported to be mediated by oxidative stress (2,3) which may be enhanced by the presence of copper (2) . Copper-binding drugs have been shown to inhibit proteasome activity (10) and generate reactive oxygen species (ROS) (11) . Disulfiram chelates copper, and it may be the disulfiram-copper complex which is the toxic form of the drug (4). Many tumors contain elevated levels of copper (10) which may render them selectively susceptible to disulfiram-induced toxicity.
A potentially significant mechanism of disulfiram-induced cell death involves inhibition of proteasome activity. We report an investigation of the extent to which disulfiram's ability to induce cell death occurred through copper-or ROS-dependent mechanisms. In the SK-N-BE(2c) and UVW/NAT cancer cell lines, clonogenic survival was decreased by disulfiram treatment and the presence of copper was necessary for tumor cell kill at low, clinically achievable, concentrations of disulfiram.
Moreover, the molar ratio of disulfiram:copper was critical for cytotoxicity.
Finally, a potent radiosensitizing effect of disulfiram was demonstrated in vitro
and in vivo for the first time, and this also was copper-dependent.
MATERIALS AND METHODS

Reagents
Disulfiram (tetraethylthiuram disulfide) was purchased from SigmaAldrich (Dorset, UK) and Antabuse obtained from Actavis (Gentofte, Denmark). Stock solutions of both agents were prepared in dimethyl sulfoxide (DMSO), then diluted in culture medium (maximum DMSO concentration 0.1% v/v). All other drugs were dissolved in culture medium. All cell culture media and supplements were purchased from Invitrogen (Paisley, UK) and all other chemicals were from Sigma-Aldrich (Dorset, UK). No-carrier-added 131 I-MIBG was prepared as described previously (20) .
Cell Culture
Human neuroblastoma-derived SK-N-BE(2c) cells were purchased from the American Type Culture Collection (Manassas, VA, USA). The UVW cell line was derived from a human glioblastoma (21) . Cell lines were authenticated in-house using the AmpF/STR Identifiler kit (Applied Biosytems, Warrington, UK). SK-N-BE(2c) cells were maintained in DMEM containing 15% (v/v) fetal calf serum (FCS). UVW cells were transfected to express the NAT gene as previously described (22), and were maintained in MEM, containing 10% (v/v) FCS and 1 mg/ml geneticin at 37ºC in a 5% CO 2 atmosphere. seeded for clonogenic assay as previously described (19, 20) .
Clonogenic Survival Assay
Spheroid Growth Assay
Multicellular spheroids were used for the evaluation of 131 I-MIBG treatment because beta-particle cross-fire irradiation makes a considerable contribution to its efficacy. This component of tumor cell kill would be under-represented in cellular monolayers (23) . SK-N-BE(2c) and UVW/NAT cells were cultured as multicellular tumor spheroids using the liquid overlay technique (24) . Briefly, spheroids were initiated by inoculating cells into an agar-coated flask. After 3 to 4 days, spheroids were retrieved by centrifugation and resuspended in fresh serum-free culture medium containing disulfiram and/or copper for 24 h.
Simultaneously, 131 I-MIBG was added to the medium at a final concentration of 1 MBq/ml for SK-N-BE(2c) and 0.5 MBq/ml for UVW/NAT spheroids.
After treatment, spheroids were washed twice and those of approximately 100 μm in diameter were transferred individually into agar-coated wells of 24-well plates. Individual spheroid growth was monitored twice per week using an inverted phase-contrast microscope connected to an image acquisition system.
Two perpendicular diameters, d max and d min , were measured using image analysis software (ImageJ) and the volume, V (μm 3 ), was calculated using the
Combination Treatments
The cytotoxic interaction between disulfiram and radiation was examined using clonogenic assay, according to the method of Chou and 
Statistics
Data are presented as means ± standard error of the mean (SEM), unless otherwise stated, with the number of independent repetitions provided in the legend to each figure. Statistical significance was determined using Student's t test. A P value < 0.05 was considered to be statistically significant and < 0.01 highly significant.
RESULTS
Disulfiram's Cytotoxicity
Escalating concentrations of disulfiram caused a biphasic toxicity profile in SK-N-BE(2c) cells (Figure 1 ). Initial clonogenic kill was maximal after administration of 1.7 µM disulfiram. Increasing disulfiram beyond this concentration resulted in partial reversal of cytotoxicity, up to 10 µM disulfiram. Thereafter, cytotoxicity increased and, following the administration of 17 µM disulfiram, clonogenic survival was 10% of untreated control levels (Fig. 1A) . The effect on clonogenic survival of the clinical formulation of disulfiram used in animal studies, Antabuse (Actavis), was also evaluated. A concentration-dependency profile similar to that generated by disulfiram was observed (Fig. 1A) .
A glioma cell line transfected with the NAT gene, UVW/NAT, responded in an analogous manner with respect to clonogenic cell kill in response to a range of concentrations of disulfiram (Fig. 1B) . Again, the initial clonogenic survival nadir was observed following treatment with 1.7 µM disulfiram. A similar biphasic dose-toxicity profile was also observed when UVW/NAT cells were exposed to Antabuse (Fig. 1B ).
Disulfiram's Biphasic Dose-Response
Treatment with 1 mM of the antioxidant NAC alone had no significant effect, but prevented the reduction in clonogenic survival of SK-N-BE(2c) cells and UVW/NAT cells induced by concentrations of disulfiram > 10 µM, whereas NAC had no significant effect on disulfiram-induced toxicity at concentration ≤ 10 µM (Fig. 1) . Therefore, a ROS-independent mechanism of cell kill predominated at low concentrations of disulfiram (≤ 10 µM).
Although bathocuproine disulfonic acid (BCPD) alone had no significant effect, the disulfiram-induced reduction in clonogenic survival of SK-N-BE(2c) cells was prevented by BCPD, at 300 µM, in the first phase of the dose-response, up to and including 10 µM disulfiram, suggesting a role for copper in disulfiram-induced cytoxicity at low concentrations. Although UVW/NAT cells were more resistant to disulfiram, the initial, maximal, clonogenic cell kill observed following treatment with 1.7 µM disulfiram was also prevented by BCPD (Fig. 2B) .
Effect of Copper on Disulfiram's Cytotoxicity
In serum-free medium and in the absence of copper, disulfiram, at concentrations up to 10 µM, induced no significant reduction in survival of either SK-N-BE(2c) or UVW/NAT clonogens (Fig. 3) , whereas the inclusion of copper chloride in the incubation medium resulted in dose-dependent clonogenic cell kill. This was maximal when disulfiram and copper concentrations were equimolar (Fig. 3 ). These observations suggest not only that the presence of copper is important for the cytotoxicity of disulfiram, but also that the concentration of copper relative to disulfiram is a major determinant of disulfiram's potency.
Copper-Dependence of Disulfiram's Radiosensitization
To investigate the potential for disulfiram to act as a radiosensitizer, SK-N-BE(2c) cells were γ-irradiated alone or in combination with disulfiram.
A radiation dose-response was clearly demonstrated with enhancement of the radiation-induced clonogenic kill by disulfiram at all radiation doses (Fig. 4) . (Fig. 6 ).
Antitumor Activity of Disulfiram and Radiation
The anti-tumor effect of disulfiram alone or in combination with radiation treatment was studied in vivo using subcutaneous tumor xenografts grown in athymic mice. None of the animals in this study showed signs of distress. Alternative radiation modalities were examined -external beam γ-rays from a 60 Co-cobalt source and the NAT-seeking radiopharmaceutical 131 I-MIBG administered by intraperitoneal injection.
Although disulfiram alone had no significant effect on tumor growth, the growth inhibitory effect of γ-radiation or 131 I-MIBG was enhanced by combination treatment with disulfiram in both tumor types (Fig. 7) . The times after treatment for 4-fold (SK-N-BE(2c)) or 10-fold (UVW/NAT) increase in tumor volume (τ 4 or τ 10 ) are shown in Table 2 . These results indicate that combination treatment with disulfiram and radiation produced a greater tumor growth delay than either agent alone, and this was apparent in 2 different xenograft models, and using 2 different sources of radiation.
DISCUSSION
In response to treatment of neuroblastoma and glioma cells with disulfiram, we observed a biphasic pattern of clonogenic cell kill. Similar dose-response patterns have been reported in disulfiram-treated myeloma cells (27) , in murine leukemia cell lines incubated with the reduced form of disulfiram (DDC) (28) and in pheochromocytoma cells treated with the structurally-related compound pyrrolidine dithiocarbamate (PDTC) (29) .
It has been suggested that many of the effects of disulfiram are due to its ability to induce oxidative stress. For example, disulfiram depleted antioxidant levels in rat cortical astrocytes (2) and elevated ROS levels in melanoma cells (3) . Moreover, disulfiram's toxicity to melanoma cells was prevented by exogenous antioxidants (3) . In the present study, the antioxidant NAC prevented the reduction in clonogenic survival induced only by high concentrations (> 10 µM) of disulfiram, but had no effect on disulfiraminduced toxicity at lower concentrations. Clinical studies have indicated that after a single oral dose of 500 mg, or repeated doses of 250 mg, plasma concentrations of disulfiram were less than 2 µM (30, 31) . Therefore, a ROSindependent mechanism is expected to predominate at clinically achievable concentrations of disulfiram.
PDTC is structurally similar to disulfiram and has been shown to cause serum-dependent apoptosis of breast tumor cells (32) . We also observed that the presence of serum was necessary for disulfiram-induced toxicity at low (< It has been suggested that proteasome inhibitors may be effective radiosensitizers (13) . Therefore it is possible that disulfiram or its metabolites have radiosensitizing properties. Indeed, DDC has previously been shown to enhance radiation sensitivity in rapidly proliferating cells (14) . We observed that disulfiram acted synergistically with γ-radiation to potentiate clonogenic cell kill at all levels of toxicity. The clonogenic survival of cells exposed to γ- The effect of treatment on the time taken for 4-fold or 10-fold increases (τ 4 
